Related Experiment Video
Updated: Sep 27, 2025

Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
Neuronal genetic rescue normalizes brain network dynamics in a lysosomal storage disorder despite persistent storage
Rebecca C Ahrens-Nicklas1, Luis Tecedor2, Arron F Hall3
1Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
In CLN3 disease, a common pediatric dementia, neuronal Cln3 loss, not storage buildup, causes brain dysfunction. Neuron-specific gene therapy normalized neural network function, suggesting new therapeutic targets.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Lysosomal storage disorders (LSDs) often cause neurologic symptoms, but mechanisms of brain dysfunction remain unclear.
- A key question is whether storage accumulation directly causes defects or is a bystander.
- The impact of cell-type-specific gene loss in LSDs is largely unknown.
Purpose of the Study:
- To investigate the impact of cell-type-specific genetic rescue on neural circuit dysfunction in CLN3 disease.
- To determine if neuronal or astrocytic Cln3 restoration corrects network abnormalities.
- To clarify the role of storage accumulation versus neuronal dysfunction in CLN3 disease pathogenesis.
Main Methods:
- Utilized a CLN3 disease mouse model.
- Employed AAV-mediated gene delivery for Cln3 expression restoration.
- Performed conditional genetic rescue in specific cell types (neurons and astrocytes).
- Assessed electrophysiologic markers of neural network function.
Main Results:
- Low-level Cln3 expression rescue specifically in neurons normalized electrophysiologic markers of network dysfunction.
- Neuronal rescue was effective despite persistent histopathology and storage.
- Restoring Cln3 expression in astrocytes did not normalize network function.
Conclusions:
- Loss of CLN3 function in neurons, not storage accumulation, is the primary driver of neurologic dysfunction in CLN3 disease.
- Targeting neuronal Cln3 restoration is a promising therapeutic strategy.
- Storage clearance may not be an effective therapeutic target or biomarker for CLN3 disease.
Related Concept Videos
Lysosomal Hydrolases
Neural Regulation
Long-term Potentiation
Neurogenesis and Regeneration of Nervous Tissue

